REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

Recruiting now

Conditions studied: Alzheimer Disease

In brief

The purpose of this study is to evaluate safety of REXULTI in patients under daily clinical settings. In addition, information on efficacy will be collected.

Key facts

Study ID

NCT06875986

Run by

Otsuka Pharmaceutical Co., Ltd.

People needed

200

Starts

2025-04-17

Expected to finish

2028-09-23

Last updated by the study team

2025-07-02

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with Alzheimer's disease

Where it is running

• Pharmacovigilance Department — Osaka, Osaka, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.